Tenderwize
Zurück zur Suche

Supply of pharmaceutical products for MBAL Dr. Hristo Stambolski in Kazanlak

МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р ХРИСТО СТАМБОЛСКИ ЕООД·гр. Казанлък, Bulgaria·BGN 185k·Deadline Apr 07, 2027 · 225 days left·Restricted·Supplies·DPS
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти, които не са включени в Приложение 2 на ПЛС, за нуждите на МБАЛ „Д-р Христо Стамболски „ ЕООД гр.Казанлък

66/100

Opportunity Score

PromisingMedium complexity
SuppliesDPSOpen
Warum diese Bewertung?

Chance

66 / 100

Komplexität

62 / 100

Risikofaktoren

The product list and quantities may change during the DPS, so pricing and supply planning may need to accommodate evolv...

Forecast quantities are explicitly non-binding, so awarded volume may be lower or different than indicated.

Restricted procedure — pre-qualification required

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • BGN 185k estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Supply of medicinal products not included in Appendix 2 of the positive drug list.
  • Procurement is organised as a dynamic purchasing system (DPS) for future specific orders.
Vollständige Zusammenfassung anzeigen

Open Bulgarian DPS for supply of pharmaceutical products not included in Appendix 2 of the positive drug list, for MBAL "Dr. Hristo Stambolski" EOOD in Kazanlak. The DPS runs for 24 months, individual contracts under it run for 12 months and may be extended by up to 6 additional months in the stated cases. Submission is electronic and the process is restricted, but the DPS is described as open to any candidate meeting the selection criteria. Estimated overall contract value is BGN 185,000.

Risiken

The product list and quantities may change during the DPS, so pricing and supply planning may need to accommodate evolv...

Forecast quantities are explicitly non-binding, so awarded volume may be lower or different than indicated.

Restricted procedure — pre-qualification required

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Dynamic purchasing system duration is 24 months.
  • Specific contracts under the DPS are for 12 months and may be extended by the contracting authority by written notice until a follow-on procedure is completed or under Article...

Administrative

  • Electronic submission is required.

Zuschlagskriterien

Lot 1

Price criterion: lowest price, evaluated on unit price excl. VAT per medicinal product.

Auftraggeber

Ort

гр. Казанлък, BGR

Auftraggeberprofil

Profil öffnen

Kennung

123540775

Tätigkeit

Health

Lose (1)

LOT-0001

Supply of pharmaceutical products for MBAL Dr. Hristo Stambolski in Kazanlak

Supply of pharmaceutical products not included in Appendix 2 of the positive drug list for the hospital’s needs. The technical specification may be partially changed during the DPS by adding new products and/or changing quantities. Quantities in the initial specification are forecast only and do not create an obligation to order the forecast volume. Scope comes from structured data and notice text.

SuppliesDPSEU fundedElectronic submission

BGN 185k

Geschätzter Wert

Ort

Казанлък, Bulgaria

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Frist

Deadline Apr 07, 2027

Vergabedetails

Veröffentlichungsdatum
15 Apr 2025
Sprachen
Bulgarian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
248382-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3